Designing Onco-Selectively Translated mRNA by Using Machine Learning
Time: 11:00 am
day: Conference Day One
Details:
- How to precisely target oncotherapeutics to cancer cells only, while avoiding healthy tissue, can broaden a drug’s therapeutic window and avoid harmful off-target effects?
- Integrating multiple public and proprietary data sources (including proteomics and transcriptomics) to identify mRNA sequence elements that enable selective translation only in cells of interest
- Outlining how our robust computational pipeline can simultaneously identify these sequence elements while generating testable hypotheses about associated biomarkers for patient stratification
